UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (date of earliest event reported):
October 7, 2005
Aastrom Biosciences, Inc.
(Exact name of registrant as specified in its charter)
| | | | | |
Michigan
(State or other jurisdiction of
incorporation) | | 0-22025
(Commission File No.) | | 94-3096597
(I.R.S. Employer
Identification No.) |
24 Frank Lloyd Wright Drive
P.O. Box 376
Ann Arbor, Michigan 48106
(Address of principal executive offices)
Registrant’s telephone number, including area code:
(734) 930-5555
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.03 Amendments to Articles of Incorporation as Bylaws; Change in Fiscal Year.
Effective as of October 7, 2005, Aastrom Biosciences, Inc. amended its Articles of Incorporation, as previously approved by the Company’s stockholders at the Annual Meeting held on November 12, 2003, to increase the number of authorized shares of common stock from 150 million to 200 million. A copy of the entire Article III of the Articles of Incorporation, as amended, is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
| | | |
| Exhibit No. | | Description |
| | | |
| 99.1 | | Article III of the Articles of Incorporation, as amended. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | Date: October 11, 2005
AASTROM BIOSCIENCES, INC.
| |
| | By: | /s/ Gerald D. Brennan, Jr. | |
| | | Gerald D. Brennan, Jr. | |
| | | Vice President, Administrative and
Financial Operations; Chief Financial
Officer | |
| |
3
